Stockscreener 앱 받기
8.69
3.33%
0.28
시간 외 거래:
8.68
-0.010
-0.12%
Ginkgo Bioworks Holdings Inc 주식(DNA)의 최신 뉴스
Ginkgo Bioworks (NYSE: DNA) insider logs RSU vesting and small tax-related share sale - Stock Titan
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery - Investing News Network
New AI lab service aims for fewer dead ends in drug discovery - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - MSN
Ginkgo Bioworks Holdings (DNA) Price Target Decreased by 11.11% to 10.88 - MSN
Steve Coen (DNA) files Form 144 to sell 307 Class A shares - Stock Titan
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance
DNA Technical Analysis | Trend, Signals & Chart Patterns | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Trading the Move, Not the Narrative: (DNA) Edition - Stock Traders Daily
Ginkgo Bioworks Announces Presentations at the Upcoming American - GuruFocus
Viking Global (DNA) reports 3,577,128 shares, removes retired reporting person - Stock Titan
Ginkgo Bioworks (DNA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Ginkgo Bioworks Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:DNA) 2026-05-13 - Seeking Alpha
Ginkgo Bioworks slumps 14% after projecting FY26 cash burn of $125M-$150M - MSN
Ginkgo outlines $125M-$150M 2026 cash burn guidance while expanding Nebula to 103 racks - MSN
Ginkgo Bioworks: Another Lost Year (NYSE:DNA) - Seeking Alpha
Austin Che files Form 144 to sell Class A shares (NASDAQ: DNA) - Stock Titan
These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - Moomoo
The Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Have Been Trimming Their Sales Forecasts - Yahoo Finance
The $59B Quiet Shift Reshaping How Patients Access Care - Benzinga
How The Ginkgo Bioworks (DNA) Story Is Shifting After The Biosecurity Divestiture And Target Cut - Yahoo Finance
William Blair Maintains Ginkgo Bioworks(DNA.US) With Sell Rating - Moomoo
TradingKey - TradingKey
Number of shareholders of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Ginkgo Bioworks Q1 Earnings Call Highlights - Barchart.com
Ginkgo Bioworks Earnings Call: Cash Rich, Revenue Pinched - TipRanks
DNA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2026 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Holdings (DNA) TTM Net Loss Of US$312.8 Million Reinforces Bearish Narratives - Sahm
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo Finance
Ginkgo Bioworks slumps 14% after projecting FY26 cash burn of $125M-$150M (DNA:NYSE) - Seeking Alpha
TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenging Waters with a Pioneering Vision - DirectorsTalk Interviews
Ginkgo Bioworks Previously Reported Fincl Results for Comparable Periods Retrospectively Recast >DNA - Moomoo
Earnings call transcript: Ginkgo Bioworks Q1 2026 sees revenue drop, restructuring efforts noted - Investing.com Canada
Ginkgo Bioworks : Q1 2026 Results (Dial-In Information) - marketscreener.com
Ginkgo Bioworks : Q1 2026 Results Presentation - marketscreener.com
Ginkgo Bioworks : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Ginkgo Bioworks Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ginkgo Bioworks Holdings Inc. (DNA) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
Ginkgo Bioworks reports Q1 revenue decline, reaffirms cash burn By Investing.com - Investing.com South Africa
Ginkgo Bioworks reports Q1 revenue decline, reaffirms cash burn - Investing.com
Ginkgo Bioworks (NYSE: DNA) posts Q1 2026 loss and exits Biosecurity unit - Stock Titan
[8-K] Ginkgo Bioworks Holdings, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab - Fidelity
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab – Company AnnouncementFT.com - Financial Times
(DNA) Volatility Zones as Tactical Triggers - Stock Traders Daily
An undisclosed buyer acquired Biosecurity business of Ginkgo Bioworks Holdings, Inc. - marketscreener.com
MSN Money - MSN
Benchling Launches One-Click Ordering for Biopharma R&D with Twist Bioscience, Adaptyv, and Ginkgo Bioworks - Yahoo Finance
0.98%
0.12%
자본화:
|
볼륨(24시간):